Monthly Communication Report

Corporation:	AbbVie Corporation
Associated registration:	963671-15270-47
Communication date:	2026-04-15
Posted date:	2026-05-15

Designated Public Office Holders who participated in the communication:	Jocelyne Voisin, Senior Assistant Deputy Minister Health Policy Branch, Health Canada (HC) Sandenga Yeba, Director of Policy & Deputy Chief of Staff Office of the Minister of Health, Health Canada (HC) Pamela Aung-Thin, Assistant Deputy Minister Health Products and Food Branch, Health Canada (HC) Elizabeth  Wong, Policy Advisor Office of the President of the Treasury Board, Treasury Board Of Canada Secretariat (TBS) Nasser Haidar, Senior Policy Advisor Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy, Intergovernmental Affairs Secretariat (IGA) Ritu Banerjee, Assistant Deputy Minister Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada (ISED) Maggie Chi, Member of Parliament House of Commons Annahat Kochhar, Policy Advisor Office of the President of the Treasury Board, Treasury Board Of Canada Secretariat (TBS) Shalene Curtis-Micallef, Deputy Minister Deputy Minister's Office, Health Canada (HC) Justine Frame, Policy Advisor Minister's Office, Health Canada (HC) Mackenzy Metcalfe, Policy Advisor Office of the Minister of Finance, Finance Canada (FIN)
List of Details Subject matter Detail Health, Industry, Intellectual Property, International Trade Communication regarding free trade agreements as they relate to the biopharmaceutical industry. Health Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape. Health, International Trade Engagement with Health Canada’s Regulatory Operations & Enforcement branch regarding supply chain resilience & integrity; mitigating and alleviating drug shortages. Economic Development, Health, Industry, Intellectual Property Patented Medicine Prices Review Board (PMPRB) Guidelines with regard to prices charged by Rights Holders for patented medicines sold in Canada.
Responsible Officer who filed this communication report:	Arima Ventin
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.